A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty ...

One of my employees, “Pam,” has been having pains that I won’t specify for the sake of anonymity. Her condition is ...

Algiax Pharmaceuticals, a company committed to developing innovative treatments for chronic neuropathic pain, has released ...

Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...

When THC attaches to the receptor, the effect is like an off switch to a light bulb, effectively turning "off" the pain. But ...

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...

CenExel, a leading network of clinical research sites, proudly congratulates and announces its role in supporting Vertex Pharmaceuticals’ clinical studies that led to the FDA approval of JOURNAVX™ ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

It is important to add pain management to leprosy treatment protocols. This can reduce the challenges that patients face. Read on.

Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

Metastatic breast cancer can come with many physical changes that can be noticeable and impact daily functioning, but there ...